Dulan Lokuwithana
Senior Healthcare News Editor at Seeking Alpha
🧡 Senior healthcare news editor @seekingalpha – connecting the dots between healthcare and Wall Street; Ex-Moody's, 🎓Edu.: CFA (US), CIMA (UK) & USJP 🇱🇰
Articles
-
1 week ago |
seekingalpha.com | Dulan Lokuwithana
Maksim Labkouski Shares of Channel Therapeutics (NYSE:CHRO) surged on Thursday after the pain therapy developer agreed to merge with Ligand Pharmaceuticals (NASDAQ:LGND) subsidiaries Pelthos Therapeutics and LNHC in a deal expected to close in the summer of 2025. The transaction is backed
-
1 week ago |
seekingalpha.com | Dulan Lokuwithana
Obesity drug developers Structure Therapeutics (NASDAQ:GPCR) and Metsera (NASDAQ:MTSR) recorded sharp gains alongside Eli Lilly (NYSE:LLY) on Thursday after the Indiana-based pharma giant reported Phase 3 data for its oral GLP-1 agonist orforglipron in type 2 diabetes.
-
1 week ago |
seekingalpha.com | Dulan Lokuwithana
Sundry Photography/iStock Editorial via Getty Images Swiss biopharma Addex Therapeutics (NASDAQ:ADXN) announced Thursday that Johnson & Johnson (NYSE:JNJ) has returned all development and commercialization rights linked to its epilepsy candidate ADX71149, ending a more than 20-year-long partnership between the two firms. J&J’s decision comes nearly nine
-
1 week ago |
seekingalpha.com | Dulan Lokuwithana
CVS Health (NYSE:CVS) said it will close more than 20 pharmacies in Arkansas after the state Gov. Sarah Huckabee Sanders signed a law banning pharmacy benefit managers ((PBMs)) from owning or operating pharmacies, marking the first of its kind legislation to pass in
-
1 week ago |
seekingalpha.com | Dulan Lokuwithana
Elevance Health (NYSE:ELV) on Thursday issued its preliminary financial results for Q1 2025, projecting $9.61 of GAAP net income and $11.97 of non-GAAP net income on a diluted per share basis, exceeding $11.38 projected by analysts. In a regulatory filing
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 287
- Tweets
- 4K
- DMs Open
- No
RT @CharlesMBrenner: wrong they introduced 20 mutations into living wolves that made them bigger and whiter they did not de-extinct the…
RT @kaylatausche: At the HHS building in Rockville, employees describe learning they were laid off when their badge doesn't work - and then…
RT @PDRennert: VEGF/PD-1 pathway bispecifics: Hype versus Hope https://t.co/4TIlU75N1U https://t.co/NI4c1cSpq4